Recurrence of hepatocellular carcinoma after radiofrequency ablation in a poor-risk patient with chronic renal failure and other complications successfully treated with stereotactic body radiotherapy-Reference-Cited by-同舟云学术

Recurrence of hepatocellular carcinoma after radiofrequency ablation in a poor-risk patient with chronic renal failure and other complications successfully treated with stereotactic body radiotherapy

Published:2022-11-29 Issue:2 Volume:16 Page:216-223
ISSN:1865-7257
Container-title:Clinical Journal of Gastroenterology
language:en
Short-container-title:Clin J Gastroenterol

Author:

Saito Toyokazu,Takakusagi Satoshi^ORCID,Takagi Hitoshi^ORCID,Yokoyama Youzo,Kizawa Kazuko,Marubashi Kyoko,Kosone Takashi,Kiyohara Hiroki^ORCID,Shibuya Kei,Uraoka Toshio^ORCID

Publisher

Springer Science and Business Media LLC

Subject

Gastroenterology,General Medicine

Link

https://link.springer.com/content/pdf/10.1007/s12328-022-01734-1.pdf

Reference35 articles.

1. Macias RIR, Monte M, Serrano M, et al. Impact of aging on primary liver cancer: epidemiology, pathogenesis and therapeutics. Aging. 2021;13:23416–34.

2. Brunot A, Sourd SL, Pracht M, et al. Hepatocellular carcinoma in elderly patients: challenges and solutions. J Hepatocell Carcinoma. 2016;3:9–18 (eCollection 2016).

3. Takakusagi S, Takagi H, Kosone T, et al. Prognosis of late elderly patients with chronic hepatitis C after achieving a sustained viral response by direct-acting antivirals. JGH Open. 2020;5:122–7 (eCollection 2021 Jan).

4. Ikuta S, Kobayashi N, Yasuda M, et al. Treatment of elderly patients with cardiovascular disease who have multiple complications and comorbidities. J Jpn Coron Assoc. 2012;18:98–102.

5. Kokudo N, Takemura N, Hasegawa K, et al. Clinical practice guidelines for hepatocellular carcinoma: the Japan society of hepatology 2017(4th JSH-HCC guide lines). Hepatol Res. 2019;49:1109–13.